News & Updates

Show Multimedia Only
HCC risk in CHB patients persists 12 years after HBsAg loss HCC risk in CHB patients persists 12 years after HBsAg loss

HCC risk in CHB patients persists 12 years after HBsAg loss

21 Mar 2023 byChristina Lau

Patients with chronic hepatitis B (CHB) still have a non-negligible risk of hepatocellular carcinoma (HCC) 12 years after achieving hepatitis B surface antigen (HBsAg) seroclearance, especially if cirrhosis is present, a large territory-wide real-world study in Hong Kong has shown.

21 Mar 2023
Novel meningitis/encephalitis CSF testing shortens antiviral prescribing duration

Novel meningitis/encephalitis CSF testing shortens antiviral prescribing duration

16 Mar 2023

The duration of antiviral prescribing has become much shorter with the introduction of the Biofire Filmarray meningitis/encephalitis (M/E) panel, a study has shown. However, its influence on antibiotic prescribing or health services in a paediatric hospital is minimal.

16 Mar 2023
What are the signs of HSV infection in patients with pemphigus vulgaris?

What are the signs of HSV infection in patients with pemphigus vulgaris?

13 Mar 2023

Clinicians must be aware of the likelihood of infection with herpes simplex virus (HSV) in the presence of fissures, haemorrhagic crusts, linear erosions, erosions with angulated margins, and increased erythrocyte sedimentation rate among patients with pemphigus vulgaris, suggests a study.

13 Mar 2023
Outpatient oritavancin reduces hospitalization in acute uncomplicated cellulitis

Outpatient oritavancin reduces hospitalization in acute uncomplicated cellulitis

13 Mar 2023

Outpatient oritavancin therapy for patients with acute uncomplicated cellulitis results in a decrease in 30-day hospital readmissions or admissions when compared with inpatient standard of care (SoC), a recent study has shown.

13 Mar 2023